Aspartic Acid

Aspartic Acid

SCHEMBL30218656

CC(=O)[C@@](O)(CC(=O)[O-])C[N+](C)(C)C.N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SSTR1SSTR2SSTR3SSTR5

The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 5/20 0.35
CPT2 P23786 1/20 0.35
CPT1A P50416 1/20 0.35
CA4 P22748 1/20 0.33
GRIK2 Q13002 2/20 0.32
SLC7A5 Q01650 1/20 0.32
BHMT Q93088 1/20 0.31
GRIA4 P48058 1/20 0.30
GRIK3 Q13003 1/20 0.30
GRIK5 Q16478 1/20 0.30
GRM1 Q13255 1/20 0.30
GRM2 Q14416 1/20 0.30
SLC22A16 Q86VW1 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Hydroxybutyric Acid, (+/-)- SCHEMBL30300556 0.83 SLC22A16 (0.35) CPT2CPT1ACA4SLC22A16MAPT
SCHEMBL30160923 0.82 CA4 (0.46) CPT2CPT1ACA4SLC22A16
SCHEMBL29497518 0.82 CA4 (0.46) CPT2CPT1ACA4SLC22A16
Cadaverine Tartrate SCHEMBL29949245 0.81 CA4 (0.37) CA4SLC22A16
Hydrochloric Acid SCHEMBL30446529 0.80 CA4 (0.45) CPT2CPT1ACA4SLC22A16
Hydrochloric Acid SCHEMBL31574660 0.80 CA4 (0.45) CPT2CPT1ACA4SLC22A16
Pyruvate SCHEMBL29497569 0.79 CA4 (0.41) CA4
Fumaric Acid SCHEMBL30455914 0.76 CA4 (0.38) CA4
SCHEMBL29623681 0.75 CPT2 (0.35) CPT2CPT1ACA4SLC22A16MAPT
SCHEMBL30065458 0.75 CA4 (0.37) CPT2CPT1ACA4SLC22A16

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4125858-A1 NUTRITIONAL COMPOSITION COMPRISING CARNITINE AND METHOD FOR TREATING OR PREVENTING AN INFECTION IN A MAMMAL Lonza Consumer Health Inc. (US) 2023-02-08 EP claimed
EP-4125858-A1 NUTRITIONAL COMPOSITION COMPRISING CARNITINE AND METHOD FOR TREATING OR PREVENTING AN INFECTION IN A MAMMAL Lonza Consumer Health Inc. (US) 2023-02-08 EP disclosed